← All stocks

Tarsus Pharmaceuticals, Inc.

TARS Scheduled selling only

CIK 0001819790 #1728 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$4.21M

$4.21M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 11 sales

Net

−$4.21M

$0.00 against sales at will

By person

14 insiders · 11 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lin Elizabeth Yeu

Chief Medical Officer

—

$2.12M (7) scheduled

−$2.12M

16,177

0.0369%

$1.38M

−51.4%

Azamian Bobak R.

President/CEO and Board Chair

—

$1.71M (3) scheduled

−$1.71M

1,709,403

3.90%

$145.30M

−2.7%

Neervannan Seshadri

Chief Operating Officer

—

$387.94K (1) scheduled

−$387.94K

79,482

0.1811%

$6.76M

+18.2%

LINK WILLIAM J PHD

Director

—

106,786

0.2433%

$9.08M

−39.9%

Wahl Bryan

General Counsel

—

63,959

0.1457%

$5.44M

+50.0%

Mottiwala Aziz

Chief Commercial Officer

—

61,480

0.1401%

$5.23M

+11.5%

Farrow Jeffrey S

See Remarks

—

56,801

0.1294%

$4.83M

+213.2%

Whitfield Dianne C.

Chief Human Resources Officer

—

35,028

0.0798%

$2.98M

+2.5%

Goldberg Andrew D.

Director

—

19,654

0.0448%

$1.67M

+209.5%

YARNO WENDY L

Director

—

16,654

0.0380%

$1.42M

+60.9%

CHAUDHURI BHASKAR

Director

—

11,654

0.0266%

$990.59K

+117.8%

Morrison Scott W

Director

—

7,638

0.0174%

$649.23K

+27.0%

Goodrich Katherine

Director

—

2,233

0.0051%

$189.81K

—

PYOTT DAVID E I

Director

—

1,383

0.0032%

$117.56K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 5

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 11

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 20 Oct 2020